Skip to Main Content

Author Details

Lina Zheng
Tianjin Medical University
2014
35
15
PMIDPaper TitleJournal TitlePublished Year
37867019TEDC2 plays an oncogenic role and serves as a therapeutic target of hepatocellular carcinoma.Dig Liver Dis2024
37867019TEDC2 plays an oncogenic role and serves as a therapeutic target of hepatocellular carcinoma.Dig Liver Dis2024
38001521Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-κB pathways.Mil Med Res2023
38001521Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-κB pathways.Mil Med Res2023
37805473lncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization.Cell Mol Biol Lett2023
37805473lncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization.Cell Mol Biol Lett2023
35184410The dynamics of cell death patterns and regeneration during acute liver injury in mice.FEBS Open Bio2022
35390162Regulatory elements can be essential for maintaining broad chromatin organization and cell viability.Nucleic Acids Res2022
36171606LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway.BMC Med2022
36075900Regulation associated modules reflect 3D genome modularity associated with chromatin activity.Nat Commun2022
36266270Systems-biology analysis of rheumatoid arthritis fibroblast-like synoviocytes implicates cell line-specific transcription factor function.Nat Commun2022
36424455Protective effect of hepatocyte-enriched lncRNA-Mir122hg by promoting hepatocyte proliferation in acute liver injury.Exp Mol Med2022
35852638STARD5 as a potential clinical target of hepatocellular carcinoma.Med Oncol2022
36619764Carbapenem-resistant hypermucoviscous <i>Klebsiella pneumoniae</i> clinical isolates from a tertiary hospital in China: Antimicrobial susceptibility, resistance phenotype, epidemiological characteristics, microbial virulence, and risk factors.Front Cell Infect Microbiol2022
36604144LncRNA-Airn alleviates acute liver injury by inhibiting hepatocyte apoptosis via the NF-κB signaling pathway.Acta Biochim Biophys Sin (Shanghai)2022
35184410The dynamics of cell death patterns and regeneration during acute liver injury in mice.FEBS Open Bio2022
35852638STARD5 as a potential clinical target of hepatocellular carcinoma.Med Oncol2022
35390162Regulatory elements can be essential for maintaining broad chromatin organization and cell viability.Nucleic Acids Res2022
36619764Carbapenem-resistant hypermucoviscous <i>Klebsiella pneumoniae</i> clinical isolates from a tertiary hospital in China: Antimicrobial susceptibility, resistance phenotype, epidemiological characteristics, microbial virulence, and risk factors.Front Cell Infect Microbiol2022
36604144LncRNA-Airn alleviates acute liver injury by inhibiting hepatocyte apoptosis via the NF-κB signaling pathway.Acta Biochim Biophys Sin (Shanghai)2022
36424455Protective effect of hepatocyte-enriched lncRNA-Mir122hg by promoting hepatocyte proliferation in acute liver injury.Exp Mol Med2022
36075900Regulation associated modules reflect 3D genome modularity associated with chromatin activity.Nat Commun2022
36171606LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway.BMC Med2022
36266270Systems-biology analysis of rheumatoid arthritis fibroblast-like synoviocytes implicates cell line-specific transcription factor function.Nat Commun2022
34731001Noncoding loci without epigenomic signals can be essential for maintaining global chromatin organization and cell viability.Sci Adv2021
34731001Noncoding loci without epigenomic signals can be essential for maintaining global chromatin organization and cell viability.Sci Adv2021
34524848Parallel characterization of cis-regulatory elements for multiple genes using CRISPRpath.Sci Adv2021
34524848Parallel characterization of cis-regulatory elements for multiple genes using CRISPRpath.Sci Adv2021
33311456Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells.Cell Death Dis2020
32071306Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis.Cell Death Dis2020
31711641LncRNA Meg8 suppresses activation of hepatic stellate cells and epithelial-mesenchymal transition of hepatocytes via the Notch pathway.Biochem Biophys Res Commun2020
33311456Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells.Cell Death Dis2020
32071306Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis.Cell Death Dis2020
31711641LncRNA Meg8 suppresses activation of hepatic stellate cells and epithelial-mesenchymal transition of hepatocytes via the Notch pathway.Biochem Biophys Res Commun2020
31334813Identification of DNA motifs that regulate DNA methylation.Nucleic Acids Res2019
31695787The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition.Theranostics2019
31281502SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker.Theranostics2019
31334813Identification of DNA motifs that regulate DNA methylation.Nucleic Acids Res2019
311966271α,25-dihydroxyvitamin D3 attenuates oxidative stress-induced damage in human trabecular meshwork cells by inhibiting TGFβ-SMAD3-VDR pathway.Biochem Biophys Res Commun2019
31695787The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition.Theranostics2019
31281502SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker.Theranostics2019
311966271α,25-dihydroxyvitamin D3 attenuates oxidative stress-induced damage in human trabecular meshwork cells by inhibiting TGFβ-SMAD3-VDR pathway.Biochem Biophys Res Commun2019
27940233Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii.Acta Trop2017
28468817Assessment of Single Cell RNA-Seq Normalization Methods.G3 (Bethesda)2017
28502705BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.Biochim Biophys Acta Mol Basis Dis2017
28424680Induction of Protective Immunity against <i>Toxoplasma gondii</i> in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP).Front Microbiol2017
28747678The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways.Nat Commun2017
28965947Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling.Biochem Biophys Res Commun2017
27940233Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii.Acta Trop2017
28296235The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-κB-dependent manner.FEBS J2017
  • 1 - 50 of 70

Recommended Authors

Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
USC Libraries Bioinformatic Services of the University of Southern California
Career Start Year 2012
Number of shared co-authors 0
Institute for Cancer Genetics, Columbia University Irving Medical Center
Career Start Year 2011
Number of shared co-authors 0
West China Hospital, Sichuan University
Career Start Year 2010
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences
Career Start Year 2009
Number of shared co-authors 0
Fuzhou University
Career Start Year 2009
Number of shared co-authors 0
The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Shanghai General Hospital, Shanghai Jiaotong University
Career Start Year 2007
Number of shared co-authors 0
Beijing University of Chinese Medicine
Career Start Year 2007
Number of shared co-authors 1
College of Bioinformatics Science and Technology, Harbin Medical University
Career Start Year 2007
Number of shared co-authors 0
The Second Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 2007
Number of shared co-authors 0
Institute of Insect Science and Technology, South China Normal University
Career Start Year 2006
Number of shared co-authors 0
University of Kansas Medical Center
Career Start Year 2006
Number of shared co-authors 0
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
National Institute of Arthritis
Career Start Year 2005
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
University of Science and Technology of China
Career Start Year 2005
Number of shared co-authors 0
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 0
Peking University International Hospital
Career Start Year 2004
Number of shared co-authors 0
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
Ningbo First Hospital, Zhejiang University
Career Start Year 2000
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
the Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Career Start Year 2000
Number of shared co-authors 0
Institute of Pathogens and Vectors, Dali University
Career Start Year 1998
Number of shared co-authors 0
Research Institute, National Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Obstetrics and Gynecology Hospital of Fudan University
Career Start Year 1997
Number of shared co-authors 0
International Academy of Phronesis Medicine
Career Start Year 1993
Number of shared co-authors 0
Institute of Biomedical Sciences, Henan Academy of Sciences
Career Start Year 1991
Number of shared co-authors 1
The Chinese University of Hong Kong
Career Start Year 1979
Number of shared co-authors 1

Collaborators

IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill
Co-authored papers 8
Co-authored papers 8
Nanyang First People's Hospital Affiliated to Henan University
Co-authored papers 6
Co-authored papers 4
Co-authored papers 4
University of California
Co-authored papers 3
University of California
Co-authored papers 3
Co-authored papers 3
University of California
Co-authored papers 3
The Ninth People's Hospital of Chongqing
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
First Hospital of Jilin University
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Max Planck Institute of Biochemistry
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1